Literature DB >> 22237394

Therapeutics: Keeping one step ahead.

Darren J Burgess.   

Abstract

Year:  2012        PMID： 22237394     DOI： 10.1038/nrc3211

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia.

Authors:  Leisl M Packer; Sareena Rana; Robert Hayward; Thomas O'Hare; Christopher A Eide; Ana Rebocho; Sonja Heidorn; Matthew S Zabriskie; Ion Niculescu-Duvaz; Brian J Druker; Caroline Springer; Richard Marais
Journal:  Cancer Cell       Date:  2011-12-13       Impact factor: 31.743
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.